Japanese scientists have developed ADRIANA, a non-opioid painkiller that could provide powerful relief without the dangers of addiction. With successful trials already completed, large U.S. studies ...

Intravenous (IV) fosfomycin-based combination therapy was safe and well tolerated in high-risk paediatric patients (aged 0-18 years) with multidrug-resistant (MDR) infections, with minimal adverse ...

KALAMAZOO, Mich. — The Kalamazoo Promise announced on Wednesday that eligible students attending community college will now receive 100% of their tuition as opposed to the previously instituted ...

An investigational benzamide antipsychotic significantly improved symptoms in hospitalized adults with acute schizophrenia in a phase II trial. The drug, N-methyl amisulpride, is similar to its ...

Over 1.5 million people globally experience gradual vision loss due to retinitis pigmentosa (RP). This condition comprises a group of inherited eye disorders characterized by the degeneration of cells ...

Much of the criticism brewing in Raptors Nation has centered around Brandon Ingram's relatively underwhelming production in this Cavs series. While that is entirely justified, it’s important to ...

A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show the treatment is safe and can significantly improve vision, even in severely ...

This is read by an automated voice. Please report any issues or inconsistencies here. President Trump promised housing for 6,000 veterans at the West L.A. VA campus, but the VA’s budget proposal ...

Proof-of-concept exploit code has been published for a critical remote code execution flaw in protobuf.js, a widely used JavaScript implementation of Google's Protocol Buffers. The tool is highly ...

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. Immune tolerance has long been the holy grail ...

Pancreatic cancer is one of the deadliest cancers. It killed nearly 52,000 Americans last year, many within a year of diagnosis. Now, there are some new experimental medicines with the potential to ...